Prostate Cancer - Results from #25560

The pitfalls of treating anorectal conditions after radiotherapy for prostate cancer - Abstract June 25, 2012

Equivalent normalized total dose estimates in CyberKnife radiotherapy dose delivery in prostate cancer hypofractionation regimens - Abstract June 25, 2012

Impact of edema and seed movement on the dosimetry of prostate seed implants - Abstract June 25, 2012

The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States - Abstract June 25, 2012

Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden - Abstract June 25, 2012

External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort - Abstract June 25, 2012

Cohort profile: The National Prostate Cancer Register of Sweden and Prostate Cancer Data Base Sweden 2.0 - Abstract June 25, 2012

Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy - Abstract June 25, 2012

Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy - Abstract June 25, 2012

The role of a well-trained team on the early learning curve of robot-assisted laparoscopic procedures: The example of radical prostatectomy - Abstract June 22, 2012

Psychological research and the prostate-cancer screening controversy - Abstract June 22, 2012

Next-generation prostate cancer biobanking: Toward a processing protocol amenable for the International Cancer Genome Consortium - Abstract June 22, 2012

Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: A survey by the Brazilian Society of Urology - Abstract June 22, 2012

Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: Correlation with prostate epithelial cells isolated from seminal fluid - Abstract June 22, 2012

A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancer - Abstract June 22, 2012

A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer - Abstract June 22, 2012

Diagnostics of radical prostatectomy specimens : Results of the 2009 consensus conference of the International Society of Urological Pathology - Abstract June 22, 2012

Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer - Abstract June 22, 2012

Advanced prostate cancer as a cause of oncogenic osteomalacia: An underdiagnosed condition - Abstract June 22, 2012

ASCO 2012 - An interview with Charles J. Ryan, MD: Presentation of the New Paradigms for Hormone Therapy in Prostate Cancer, clinical symposium at the ASCO 2012 Annual Meeting June 22, 2012

Page 1279 of 1437